Skip to main
CAPR
CAPR logo

Capricor Therapeutics (CAPR) Market Capitalization Overview

Market Cap: $468.51M as of Jul 3, 2025

$468.51M
Past Month-$41.14M (8.07%)
As of Jul 3, 2025, Capricor Therapeutics (CAPR) has a market capitalization of $468.51M. Over the past 30 days, its market cap has decreased by -5%, while in the last 12 months, it has decreased by -25.34%.

Market capitalization represents the total value of Capricor Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Capricor Therapeutics (CAPR) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Capricor Therapeutics (CAPR) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Capricor Therapeutics (CAPR) Market Cap History

DateMarket CapChange
Jul 1, 2025$443.37M-5.00%
Jun 2, 2025$466.68M-19.80%
May 1, 2025$581.93M+34.46%
Apr 1, 2025$432.79M-30.37%
Mar 3, 2025$621.58M-9.95%
Feb 3, 2025$690.24M+1.47%
Jan 2, 2025$680.23M-23.83%

Capricor Therapeutics (CAPR) End of Year Market Cap History

DateMarket CapChange
2025$468.51M-25.34%
2024$627.49M+316.72%
2023$150.58M+54.55%
2022$97.44M+37.70%
2021$70.76M+0.89%
2020$70.14M

FAQs About Capricor Therapeutics (CAPR) Market Cap

As of Jul 3, 2025, the market capitalization of Capricor Therapeutics (CAPR) is $468.51M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Capricor Therapeutics’s market capitalization has decreased by -8.07%, changing from $509.65M to $468.51M as of Jul 3, 2025.

In the last 3 months, Capricor Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Capricor Therapeutics’s market capitalization increased from $150.58M in January to $627.49M in December, reflecting a 316.72% change.

In the past five years, Capricor Therapeutics (CAPR) has had a compound annual growth rate (CAGR) of 55.00% in market capitalization. This means its market cap has grown at an average rate of 55.00% per year.

Capricor Therapeutics (CAPR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.